查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1662896

髓内钉市场预测至 2030 年：按产品类型、材料类型、年龄层、骨折类型、分销管道、最终用户和地区进行的全球分析

Intramedullary Nails Market Forecasts to 2030 - Global Analysis By Product Type, Material Type, Age Group, Fracture Type, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球髓内钉市值为 7.673 亿美元，预计到 2030 年将达到 11.387 亿美元，预测期内的复合年增长率为 6.8%。

髓内钉是用于稳定骨折的整形外科植入。它被插入骨的髓管（空心中心），以便在癒合过程中对齐和支撑骨碎片；这提供了内部固定。它们通常用于治疗股骨、胫骨和肱骨骨折，并具有多种设计和材质（钛、不銹钢），以满足骨折类型和患者的需求。允许早期活动并减少外固定的需要。

根据世界卫生组织 (WHO) 的数据，道路交通伤害是全球造成残疾和死亡的沉重负担，每年约有 119 万人因此死亡。

老化与骨质疏鬆症

全球人口老化，特别是60岁以上人口的老化是髓内钉市场的主要动力。骨质疏鬆症等疾病会增加骨折的风险，需要先进的整形外科解决方案。预计2050年老龄人口将达21亿，髓内钉需求将大幅增加。这些装置提供有效的骨折管理，允许更快的恢復和改善活动能力，这对老年患者来说很重要。

植入高成本

髓内钉的高价是市场成长的一大障碍，尤其是在新兴市场。儘管这些植入很有效，但对于许多患者来说，它们的价格太昂贵，限制了他们接受可能挽救生命的手术的机会。这种影响也延伸到医疗保健提供者和设施，在因成本而无法获得最佳护理的情况下，会导致患者康復时间更长、治疗效果更差。

客製化髓内钉的开发

生物分解性的指甲、内建感测器的智慧指甲和改进的锁定机制等设计和材料方面的技术进步正在改善治疗效果并扩大可有效治疗的疾病范围。那些专注于研发并向市场推出创新产品的公司能够脱颖而出并占据更大的市场占有率。

医疗报销政策变化

报销限制可能导致治疗量减少并阻碍市场扩张，尤其是在医疗预算有限的地区。髓内钉手术的报销率不足和保险覆盖范围限制给患者和提供者带来了财务障碍。社会经济差异，包括获得医疗保健、教育和资源的差异，会影响对整形外科护理的需求。

COVID-19 的影响

疫情对髓内钉市场产生了较大影响，新冠肺炎疫情尖峰时段手术量较疫情前下降了44.6%。选择性手术延后或取消，造成大量积压病例。虽然在高峰过后，手术量已恢復到疫情前水准的 85.8%，但清理积压手术所带来的预期激增尚未实现。

钛合金市场预计将成为预测期内最大的市场

由于钛合金具有强度高、重量轻、生物相容性好等特点，预计在预测期内将占据最大的市场占有率。这些材料减少了应力屏蔽并促进骨骼更快癒合，使其成为创伤手术中使用的髓内钉的理想选择。此外，钛的耐腐蚀性和耐用性确保了植入的长期稳定性，从而增加了外科医生和医疗保健提供者对其的采用。对微创整形外科手术的需求不断增长，进一步增强了该领域在市场上的主导地位。

在预计预测期内，门诊手术中心 (ASC) 部分将以最高的复合年增长率成长。

预计门诊手术中心 (ASC) 部门在预测期内将呈现最高的成长率。 ASC 的成本效益和当日手术能力使其成为医院护理的一种有吸引力的替代方案。由于恢復时间更快、住院时间更短，人们对门诊整形外科手术的偏好增加，推动了 ASC 的成长。此外，微创技术的进步和当日手术的优惠报销计划正在加速髓内钉在 ASC 中的应用，有助于市场快速扩张。

比最大的地区

预计预测期内北美地区将占据最大的市场占有率。发达的医疗基础设施、先进整形外科植入的广泛采用以及老年人骨折发病率的不断上升，共同构成了该地区的优势。市场领导参与企业的出现和整形外科创伤护理领域的持续进步进一步巩固了北美的地位。此外，优惠的报销政策和不断增加的医疗支出也支持了市场的成长。

复合年增长率最高的地区

预计预测期内亚太地区将呈现最高的复合年增长率。该地区的快速增长是由于老年人口的增加、骨质疏鬆症患者数量的增加以及人们对先进创伤治疗的认识的不断提高。印度、中国和日本等国家的医疗保健基础设施不断扩大以及医疗旅游业的兴起进一步推动了市场的成长。政府支持负担得起的整形外科治疗和增加对医疗设备製造的投资的倡议正在提升该地区的潜力。随着医疗保健机会的改善，髓内钉的需求预计将大幅增加。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场参与企业（最多 3 家公司）进行全面分析
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 介绍
  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球髓内钉市场依产品类型划分

  • 介绍
  • 股骨髓内钉
  • 胫骨髓内钉
  • 肱骨髓内钉
  • 特别指甲

6. 全球髓内钉市场（依材料）

  • 介绍
  • 防锈的
  • 钛合金

7. 全球髓内钉市场依年龄层划分

  • 介绍
  • 孩子们
  • 成人
    • 青年（18-45岁）
    • 中年（46-65岁）
    • 老年人（65岁以上）

8. 全球髓内钉市场（依骨折类型）

  • 介绍
  • 股骨骨折
    • 股骨近端骨折
    • 股骨干骨折
    • 股骨远端骨折
  • 胫骨骨折
    • 胫骨近端骨折
    • 胫骨干骨折
    • 远端胫骨（pilon）骨折
  • 肱骨骨折
    • 肱骨近端骨折
    • 肱骨干骨折
    • 肱骨远端骨折

9. 全球髓内钉市场按分销管道划分

  • 介绍
  • 直接销售
  • 分销商和零售商
  • 网上销售

第 10 章全球髓内钉市场（依最终用户）

  • 介绍
  • 医院
  • 门诊手术中心（ASC）
  • 整形外科门诊

第 11 章 全球髓内钉市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章 公司概况

  • Stryker Corporation
  • DePuy Synthes（Johnson & Johnson）
  • Zimmer Biomet
  • Smith+Nephew
  • Medtronic plc
  • B. Braun Melsungen AG
  • Orthofix Medical Inc.
  • Wright Medical Group NV
  • Orthopaedic Implant Company
  • Micromed Medizintechnik GmbH
  • GPC Medical Ltd.
  • MEDIN as
  • Pega Medical Inc.
  • Bioimpianti
  • IMECO SA
  • CarboFix Orthopedics Ltd
  • AAP Implantate AG
  • Mizuho OSI, Inc.
Product Code: SMRC28758

According to Stratistics MRC, the Global Intramedullary Nails Market is accounted for $767.3 million in 2024 and is expected to reach $1138.7 million by 2030 growing at a CAGR of 6.8% during the forecast period. Intramedullary nails are orthopedic implants used to stabilize bone fractures. Inserted into the medullary canal (hollow center) of a bone, they provide internal fixation, aligning and supporting the bone fragments during healing. Commonly used for femur, tibia, and humerus fractures, these nails come in various designs and materials (titanium, stainless steel) to suit different fracture types and patient needs. They enable early mobilization and reduce the need for external fixation.

According to the World Health Organization (WHO), road traffic injuries cause a substantial burden of disability and mortality globally, with an estimated 1.19 million deaths annually.

Market Dynamics:

Driver:

Aging population and osteoporosis

The aging global population, particularly individuals over 60, is a key driver for the intramedullary nails market. Conditions such as osteoporosis increase susceptibility to fractures, necessitating advanced orthopedic solutions. With projections indicating that the elderly population will reach 2.1 billion by 2050, the demand for intramedullary nails is expected to grow significantly. These devices provide effective fracture management, enabling faster recovery and improved mobility, which are critical for elderly patient.

Restraint:

High cost of implants

The high cost of intramedullary nails presents a significant barrier to market growth, particularly in developing regions. These implants can be prohibitively expensive for many patients despite their effectiveness, limiting access to potentially life-saving procedures. The impact extends to healthcare providers and facilities, leading to longer recovery periods and worse patient outcomes in cases where cost prevents optimal treatment.

Opportunity:

Development customized intramedullary nails

Technological advancements in design and materials, including biodegradable nails, smart nails with integrated sensors, and improved locking mechanisms, are enhancing treatment efficacy and expanding the range of conditions that can be effectively treated. Companies focusing on research and development to bring innovative products to market can differentiate themselves and capture larger market share.

Threat:

Changes in healthcare reimbursement policies

Limited reimbursement can reduce procedure volumes and hinder market expansion, particularly in regions with constrained healthcare budgets. Inadequate reimbursement rates or restrictions on coverage for intramedullary nail procedures create financial barriers for patients and healthcare providers. Socioeconomic disparities, including disparities in access to healthcare, education, and resources, can influence the demand for orthopedic treatments.

Covid-19 Impact:

The pandemic significantly impacted the intramedullary nails market, with a 44.6% decline in surgical procedure volumes during peak COVID-19 compared to pre-pandemic levels. Elective surgeries were postponed or cancelled, creating substantial backlogs. Although procedure volumes recovered to 85.8% of pre-pandemic levels in the post-peak period, the expected surge from clearing backlogs has yet to materialize.

The titanium alloy segment is expected to be the largest during the forecast period

The titanium alloy segment is expected to account for the largest market share during the forecast period due to their high strength, lightweight properties, and excellent biocompatibility. These materials reduce stress shielding and promote faster bone healing, making them ideal for intramedullary nails used in trauma surgeries. Additionally, titanium's corrosion resistance and durability ensure long-term implant stability, increasing its adoption among surgeons and healthcare providers. Growing demand for minimally invasive orthopedic procedures further boosts the segment's dominance in the market.

The ambulatory surgical centers (ASCs) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ambulatory surgical centers (ASCs) segment is predicted to witness the highest growth rate. ASCs offer cost-effective, same-day surgical procedures, making them an attractive alternative to hospital-based treatments. The increasing preference for outpatient orthopedic surgeries, driven by shorter recovery times and reduced hospital stays, fuels the growth of ASCs. Additionally, advancements in minimally invasive techniques and favorable reimbursement policies for day-care procedures enhance the adoption of intramedullary nails in ASCs, driving their rapid market expansion.

Region with largest share:

During the forecast period, North America region is expected to hold the largest market share. Factors such as a well-established healthcare infrastructure, high adoption of advanced orthopedic implants, and rising fracture cases among the elderly contribute to the region's dominance. The presence of leading market players and continuous advancements in orthopedic trauma care further strengthen North America's position. Additionally, favorable reimbursement policies and increasing healthcare expenditures support market growth.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. The region's rapid growth is driven by a rising geriatric population, increasing cases of osteoporosis, and growing awareness about advanced trauma care. Expanding healthcare infrastructure, coupled with rising medical tourism in countries like India, China, and Japan, further accelerates market growth. Government initiatives supporting affordable orthopedic treatments and increasing investments in medical device manufacturing enhance the region's potential. As healthcare accessibility improves, the demand for intramedullary nails is expected to surge significantly.

Key players in the market

Some of the key players in Intramedullary Nails Market include Stryker Corporation, DePuy Synthes (Johnson & Johnson), Zimmer Biomet, Smith+Nephew, Medtronic plc, B. Braun Melsungen AG, Orthofix Medical Inc., Wright Medical Group N.V., Orthopaedic Implant Company, Micromed Medizintechnik GmbH, GPC Medical Ltd., MEDIN a.s., Pega Medical Inc., Bioimpianti, IMECO S.A., CarboFix Orthopedics Ltd, AAP Implantate AG and Mizuho OSI, Inc.

Key Developments:

In February 2024, Smith+Nephew, the global medical technology company, announces the premiere of its newly acquired CARTIHEAL* AGILI-C* Cartilage Repair Implant alongside the REGENETEN* Bioinductive Implant at the AAOS Annual Meeting, demonstrating its leadership with products that enable biological healing for Sports Medicine. Backed by impressive clinical evidence, both technologies are transforming the way healthcare professionals treat soft tissue repair and helping improve patient outcomes versus the current standard of care.

In January 2024, Stryker announced that it expanded its Gamma4 hip fracture nailing system by adding an intermediate nail. The latest expansion received FDA 510(k) clearance in June 2023. Since its 2022 launch, Gamma4 has been used in more than 19,000 cases across more than 850 facilities. Kalamazoo, Michigan-based Stryker now incorporates the RC Lag screw and an anti-rotation clip with sleeve components in the Gamma4.

Product Types Covered:

  • Femoral Intramedullary Nails
  • Tibial Intramedullary Nails
  • Humeral Intramedullary Nails
  • Specialty Nails

Material Types Covered:

  • Stainless Steel
  • Titanium Alloy

Age Groups Covered:

  • Pediatrics
  • Adults

Fracture Types Covered:

  • Femoral Fractures
  • Tibial Fractures
  • Humeral Fractures

Distribution Channels Covered:

  • Direct Sales
  • Distributors & Retailers
  • Online Sales

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Orthopedic Clinics

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Intramedullary Nails Market, By Product Type

  • 5.1 Introduction
  • 5.2 Femoral Intramedullary Nails
  • 5.3 Tibial Intramedullary Nails
  • 5.4 Humeral Intramedullary Nails
  • 5.5 Specialty Nails

6 Global Intramedullary Nails Market, By Material Type

  • 6.1 Introduction
  • 6.2 Stainless Steel
  • 6.3 Titanium Alloy

7 Global Intramedullary Nails Market, By Age Group

  • 7.1 Introduction
  • 7.2 Pediatrics
  • 7.3 Adults
    • 7.3.1 Young Adults (18-45)
    • 7.3.2 Middle-aged (46-65)
    • 7.3.3 Geriatric (65+)

8 Global Intramedullary Nails Market, By Fracture Type

  • 8.1 Introduction
  • 8.2 Femoral Fractures
    • 8.2.1 Proximal Femoral Fractures
    • 8.2.2 Femoral Shaft Fractures
    • 8.2.3 Distal Femoral Fractures
  • 8.3 Tibial Fractures
    • 8.3.1 Proximal Tibial Fractures
    • 8.3.2 Tibial Shaft Fractures
    • 8.3.3 Distal Tibial (Pilon) Fractures
  • 8.4 Humeral Fractures
    • 8.4.1 Proximal Humeral Fractures
    • 8.4.2 Humeral Shaft Fractures
    • 8.4.3 Distal Humeral Fractures

9 Global Intramedullary Nails Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Direct Sales
  • 9.3 Distributors & Retailers
  • 9.4 Online Sales

10 Global Intramedullary Nails Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Ambulatory Surgical Centers (ASCs)
  • 10.4 Specialty Orthopedic Clinics

11 Global Intramedullary Nails Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Stryker Corporation
  • 13.2 DePuy Synthes (Johnson & Johnson)
  • 13.3 Zimmer Biomet
  • 13.4 Smith+Nephew
  • 13.5 Medtronic plc
  • 13.6 B. Braun Melsungen AG
  • 13.7 Orthofix Medical Inc.
  • 13.8 Wright Medical Group N.V.
  • 13.9 Orthopaedic Implant Company
  • 13.10 Micromed Medizintechnik GmbH
  • 13.11 GPC Medical Ltd.
  • 13.12 MEDIN a.s.
  • 13.13 Pega Medical Inc.
  • 13.14 Bioimpianti
  • 13.15 IMECO S.A.
  • 13.16 CarboFix Orthopedics Ltd
  • 13.17 AAP Implantate AG
  • 13.18 Mizuho OSI, Inc.

List of Tables

  • Table 1 Global Intramedullary Nails Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Intramedullary Nails Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Intramedullary Nails Market Outlook, By Femoral Intramedullary Nails (2022-2030) ($MN)
  • Table 4 Global Intramedullary Nails Market Outlook, By Tibial Intramedullary Nails (2022-2030) ($MN)
  • Table 5 Global Intramedullary Nails Market Outlook, By Humeral Intramedullary Nails (2022-2030) ($MN)
  • Table 6 Global Intramedullary Nails Market Outlook, By Specialty Nails (2022-2030) ($MN)
  • Table 7 Global Intramedullary Nails Market Outlook, By Material Type (2022-2030) ($MN)
  • Table 8 Global Intramedullary Nails Market Outlook, By Stainless Steel (2022-2030) ($MN)
  • Table 9 Global Intramedullary Nails Market Outlook, By Titanium Alloy (2022-2030) ($MN)
  • Table 10 Global Intramedullary Nails Market Outlook, By Age Group (2022-2030) ($MN)
  • Table 11 Global Intramedullary Nails Market Outlook, By Pediatrics (2022-2030) ($MN)
  • Table 12 Global Intramedullary Nails Market Outlook, By Adults (2022-2030) ($MN)
  • Table 13 Global Intramedullary Nails Market Outlook, By Young Adults (18-45) (2022-2030) ($MN)
  • Table 14 Global Intramedullary Nails Market Outlook, By Middle-aged (46-65) (2022-2030) ($MN)
  • Table 15 Global Intramedullary Nails Market Outlook, By Geriatric (65+) (2022-2030) ($MN)
  • Table 16 Global Intramedullary Nails Market Outlook, By Fracture Type (2022-2030) ($MN)
  • Table 17 Global Intramedullary Nails Market Outlook, By Femoral Fractures (2022-2030) ($MN)
  • Table 18 Global Intramedullary Nails Market Outlook, By Proximal Femoral Fractures (2022-2030) ($MN)
  • Table 19 Global Intramedullary Nails Market Outlook, By Femoral Shaft Fractures (2022-2030) ($MN)
  • Table 20 Global Intramedullary Nails Market Outlook, By Distal Femoral Fractures (2022-2030) ($MN)
  • Table 21 Global Intramedullary Nails Market Outlook, By Tibial Fractures (2022-2030) ($MN)
  • Table 22 Global Intramedullary Nails Market Outlook, By Proximal Tibial Fractures (2022-2030) ($MN)
  • Table 23 Global Intramedullary Nails Market Outlook, By Tibial Shaft Fractures (2022-2030) ($MN)
  • Table 24 Global Intramedullary Nails Market Outlook, By Distal Tibial (Pilon) Fractures (2022-2030) ($MN)
  • Table 25 Global Intramedullary Nails Market Outlook, By Humeral Fractures (2022-2030) ($MN)
  • Table 26 Global Intramedullary Nails Market Outlook, By Proximal Humeral Fractures (2022-2030) ($MN)
  • Table 27 Global Intramedullary Nails Market Outlook, By Humeral Shaft Fractures (2022-2030) ($MN)
  • Table 28 Global Intramedullary Nails Market Outlook, By Distal Humeral Fractures (2022-2030) ($MN)
  • Table 29 Global Intramedullary Nails Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 30 Global Intramedullary Nails Market Outlook, By Direct Sales (2022-2030) ($MN)
  • Table 31 Global Intramedullary Nails Market Outlook, By Distributors & Retailers (2022-2030) ($MN)
  • Table 32 Global Intramedullary Nails Market Outlook, By Online Sales (2022-2030) ($MN)
  • Table 33 Global Intramedullary Nails Market Outlook, By End User (2022-2030) ($MN)
  • Table 34 Global Intramedullary Nails Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 35 Global Intramedullary Nails Market Outlook, By Ambulatory Surgical Centers (ASCs) (2022-2030) ($MN)
  • Table 36 Global Intramedullary Nails Market Outlook, By Specialty Orthopedic Clinics (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.